Elite athletes find cannabidiol, or CBD, useful for soreness and recovery, a new study shows. Researchers found that top ...

A recent study has found that two cannabis derivatives may aid in ovarian cancer treatment. The research indicates that CBD ...

Reclassification to a Schedule III drug and possible Medicare coverage for pot could unlock new investment from ...

Each slowed cell growth, formed fewer and smaller clusters and prevented them from spreading. The results were most notable ...

CBD and THC—show surprisingly strong effects against ovarian cancer cells. Used together, they slow cell growth, reduce ...

The researchers also examined how the compounds affected cell signalling pathways. They found evidence that CBD and THC ...

Although our study is still preliminary, it lays an important foundation for future research into the potential applications ...

President Donald Trump's executive order reclassifying cannabis as a Schedule 3 drug could come Monday - and with it, Medicare coverage for CBD.

A proposed CMS rule hints that some Medicare plans could cover certain legal CBD products, bringing cannabinoids a step ...

A federal proposal tied to a government spending bill could soon reshape the hemp industry, making many CBD products illegal.

The government funding bill passed a month ago has a measure to cap THC levels in hemp products starting next November.

A McPherson CBD store owner is suing the Kansas Attorney General and KBI director after they authorized raids on his store in ...